Pacira BioScienc Rg
PCRX
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 17:20:00
Bid
12/27/2024 - 15:59:59
Bid
Volume
Ask
12/27/2024 - 15:59:59
Ask
Volume
19.65
-0.16 ( -0.81% )
19.65
500
19.67
200
More information
Analysis by TheScreener
24.12.2024
Evaluation Slightly negative  
Interest Strong  
Sensibility High  
Analysis date: 24.12.2024
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 08.11.2024.
Interest
  Strong
Strong interest since 06.12.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 08.11.2024 at a price of 17.24.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 04.10.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 17.675.
4wk Rel Perf
  10.89%
 
The four week relative overperformance versus SP500 is 10.89%.
Sensibility
  High
The stock has been on the high-sensitivity level since 09.08.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 6.54%.
Mkt Cap in $bn
  0.89
With a market capitalization <$2bn, PACIRA BIOSCIENCES is considered a small-cap stock.
G/PE Ratio
  0.76
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  6.24
The estimated PE is for the year 2027.
LT Growth
  4.76%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  -8
For 1% of index variation, the stock varies on average by -0.08%.
Correlation
  0
Stock movements are totally independent of index variations.
Value at Risk
  13.83
The value at risk is estimated at USD 13.83. The risk is therefore 71.04%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  19.09.2014